Treatment with Anaerobutyricum soehngenii: a pilot study of safety and dose-response effects on glucose metabolism in human subjects with metabolic syndrome.

NPJ Biofilms Microbiomes · 2020 · PMC7101376 · PMID 32221294

Europe PMC DOI

hedged sentence

0.0550

closest p · 1.1× alpha

0.0550

boldest claim

The sentences

borderline significantp = 0.055so close (0.05 < p ≤ 0.1)

There was a borderline significant difference in replication signal between the different dose groups after treatment (Kruskal–Wallis, p = 0.055), with the high-dose group showing a significantly higher Anaerobutyricum spp. replication signal compared to the low-dose group ( p = 0.018; Fig. 7 ).

also in 11,409 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.